Clinical Trials & Medical Discoveries The most recent news and results from scientific and medical research, covering all aspects of healthcare, including testing, diagnosis, and treatment. Stay up-to-date on the latest medical discoveries and breakthroughs with announcements of new products to be tested, upcoming clinical trials and studies, and newly published results. Also included are updates regarding funding decisions, company performance, and legal news.

Latest

Jul 18, 2016, 18:30 ET ACS NSQIP Data Helps Hospital Develop a Quality Improvement Assessment Tool for Reducing Urinary Tract Infection Rates Across Surgical and Non-Surgical Departments

A systematic program for analyzing processes associated with catheter placement and removal for surgical patients decreased urinary tract...


Jul 18, 2016, 09:30 ET Physician-Led Point Of Care Medication Delivery Yields Up To 30% Improvement In Key Medication Adherence

University of Miami and ChenMed investigators funded by the Robert Wood Johnson Foundation today announced that a two-year clinical study involving...


Jul 18, 2016, 09:18 ET DalCor's Dalcetrapib Demonstrates Genotype-Dependent Effects on Cholesterol Efflux and Inflammation in Data Published by The Montreal Heart Institute in Circulation: Cardiovascular Genetics

Effects on C-reactive protein and cholesterol efflux support dalcetrapib benefits on cardiovascular outcomes in patients with AA genotype of ADCY9...


Jul 18, 2016, 09:17 ET Bexion Pharmaceuticals Receives FDA Clearance for the First Clinical Trial Using BXQ-350 to Dose Patients with Cancer

Bexion Pharmaceuticals, LLC ('Bexion") announced today that the U.S. Food and Drug Administration (FDA) cleared Bexion's application to initiate a...


Jul 18, 2016, 09:00 ET Syneron Candela Announces FDA Clearance of High Energy UltraShape Power for Fat Destruction

Syneron Medical Ltd. (NASDAQ: ELOS), a leading global aesthetic device company, announces the U.S. Food and Drug Administration (FDA) clearance of...


Jul 18, 2016, 08:00 ET BrainStorm Announces Positive Top Line Results from the U.S. Phase 2 Study of NurOwn® in Patients with Amyotrophic Lateral Sclerosis (ALS)

BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today...


Jul 18, 2016, 08:00 ET Delcath Announces Acceptance Of Abstracts For Poster Presentation At CIRSE 2016

 Delcath Systems, Inc. (NASDAQ: DCTH), a specialty pharmaceutical and medical device company focused on oncology with an emphasis on the...


Jul 18, 2016, 08:00 ET Eiger BioPharmaceuticals Announces First Patient Dosed in Phase 2 LIBERTY Study of Ubenimex in Pulmonary Arterial Hypertension

Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), focused on the development and commercialization of targeted therapies for rare diseases, announced...


Jul 18, 2016, 08:00 ET MabVax Therapeutics Initiates Patient Enrollment in a Phase I Trial for a New Diagnostic Imaging Product for Pancreatic Cancer

 MabVax Therapeutics Holdings, Inc. (OTCQB: MBVX), a clinical-stage oncology drug development company, announces the initiation of patient...


Jul 18, 2016, 07:40 ET SI-BONE, Inc. Announces 40th Peer-Reviewed Publication - a Multicenter Long Term Outcomes Study Showing Durable Results With the iFuse Implant System®

 SI-BONE, Inc., a medical device company that pioneered the use of the iFuse Implant System® ("iFuse"), a triangular-shaped minimally...


Jul 18, 2016, 07:00 ET Citius Pharmaceuticals Completes Feasibility Study of Investigator Sites for Mino-Lok™ Phase 3 Trials

 Citius Pharmaceuticals, Inc. ("Citius") (OTC BB: CTXR), a specialty pharmaceutical company focused on adjunctive cancer care and critical care...


Jul 18, 2016, 07:00 ET Soligenix Announces Presentation of Positive Preliminary Results of a Heat Stable Ebola Vaccine Formulation

 Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing...


Jul 18, 2016, 06:15 ET ARIA Study Shows Superior Efficacy of Triumeq® for Treatment-naïve Women Living with HIV

ViiV Healthcare today presented 48-week data from the phase IIIb, open-label, international, multi-centre ARIA study which showed superior...


Jul 18, 2016, 06:00 ET BioLife Solutions Products Embedded in Cook MyoSite® Phase 3 Cell Therapy Clinical Trial for Stress Urinary Incontinence

 BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade cell and tissue...


Jul 18, 2016, 06:00 ET RenewSense Enters Brainnovation, Israel's Brain Technologies Accelerator

Yissum Research Development Company Ltd., the technology transfer arm of the Hebrew University of Jerusalem, today announced that RenewSense was...


Jul 17, 2016, 11:56 ET Prinz Harry schärft das Bewusstsein für HIV mit bioLyticals INSTI

Prinz Harry macht den INSTI HIV-Test live auf Social Media, um die Stigmatisierung von HIV zu verringern    bioLytical Laboratories...


Jul 17, 2016, 11:51 ET Le prince Harry sensibilise au VIH avec INSTI de bioLytical

Le prince Harry fait le test INSTI VIH en direct sur les médias sociaux afin de réduire la stigmatisation autour du VIH...


Jul 17, 2016, 08:12 ET El Príncipe Harry aumenta el conocimiento de VIH con INSTI de bioLytical

El Príncipe Harry realiza el test INSTI HIV en vivo en los medios sociales para reducir el estigma alrededor del VIH...


Jul 15, 2016, 08:00 ET Ardelyx to Raise $110 Million in a Private Placement

Ardelyx, Inc. (NASDAQ: ARDX), a clinical-stage biopharmaceutical company focused on gastrointestinal and cardio-renal diseases, today announced...